Data / Form D filings / AETHLON MEDICAL INC
AETHLON MEDICAL INC: Form D filings
AETHLON MEDICAL INC, a biotechnology company in San Diego, CA, filed 24 Form D notices with the SEC between 2009 and 2025. The latest, on December 23, 2025, reports $2.2 million sold of a $2.2 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 11555 SORRENTO VALLEY ROAD, SUITE 203, Suite 203, San Diego, CA, 92121
- Phone
- (619) 941-0360
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 882291
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | New notice | $2,153,700 | $2,153,700 | 1 | Dec 8, 2025 | sec.gov | |
| Jan 24, 2020 | New notice | $2,733,797 | $2,733,797 | 7 | Jan 22, 2020 | sec.gov | |
| Jul 9, 2015 | New notice | $6,000,000 | $6,000,000 | 19 | Jun 25, 2015 | sec.gov | |
| Dec 15, 2014 | New notice | $3,300,000 | $3,300,000 | 4 | Dec 2, 2014 | sec.gov | |
| Nov 21, 2014 | New notice | $527,780 | $527,780 | 2 | Nov 6, 2014 | sec.gov | |
| Nov 4, 2014 | New notice | $838,725 | $838,725 | 9 | Jul 29, 2014 | sec.gov | |
| Nov 4, 2014 | New notice | $913,500 | $913,500 | 14 | May 20, 2014 | sec.gov | |
| Nov 4, 2014 | New notice | $837,737 | $837,737 | 3 | Oct 20, 2014 | sec.gov | |
| Jan 9, 2014 | Amendment | $2,000,000 | $1,795,900 | $204,100 | 22 | Oct 30, 2013 | sec.gov |
| Dec 20, 2013 | Amendment | $2,000,000 | $1,525,900 | $474,100 | 19 | Oct 30, 2013 | sec.gov |
| Nov 22, 2013 | Amendment | $2,000,000 | $642,000 | $1,358,000 | 11 | Oct 30, 2013 | sec.gov |
| Nov 12, 2013 | New notice | $2,000,000 | $230,000 | $1,770,000 | 3 | Oct 30, 2013 | sec.gov |
| Oct 11, 2013 | Amendment | $5,000,000 | $2,037,834 | $2,962,166 | 27 | Jun 19, 2012 | sec.gov |
| Sep 16, 2013 | New notice | $400,000 | $400,000 | 2 | Jul 9, 2013 | sec.gov | |
| Oct 25, 2012 | New notice | $5,000,000 | $1,041,000 | $3,959,000 | 15 | Jun 19, 2012 | sec.gov |
| Feb 29, 2012 | Amendment | $1,050,000 | $1,050,000 | 10 | Nov 10, 2011 | sec.gov | |
| Dec 2, 2011 | Amendment | $1,000,000 | $525,000 | $475,000 | 5 | Nov 10, 2011 | sec.gov |
| Nov 21, 2011 | New notice | $1,000,000 | $210,000 | $790,000 | 1 | Nov 10, 2011 | sec.gov |
| May 19, 2011 | New notice | $350,000 | $350,000 | 2 | Apr 1, 2011 | sec.gov | |
| Sep 17, 2010 | New notice | $1,300,000 | $650,000 | $650,000 | 3 | Sep 3, 2010 | sec.gov |
| Jul 30, 2010 | New notice | $890,000 | $890,000 | 1 | Jul 15, 2010 | sec.gov | |
| Feb 25, 2010 | New notice | $600,000 | $600,000 | 1 | Feb 12, 2010 | sec.gov | |
| Sep 3, 2009 | New notice | $307,500 | $307,500 | 2 | Aug 24, 2009 | sec.gov | |
| Sep 3, 2009 | New notice | $300,000 | $300,000 | 1 | Jul 10, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Chetan S. Shah, M.D. | Director | |
| James B. Frakes | Executive Officer, Director | |
| Edward G. Broenniman | Director | |
| Nicolas S. Gikakis | Director | |
| Angela G. Rossetti | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Dec 22, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AETHLON MEDICAL INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.